Windtree Therapeutics, Inc. (WINT)
OTCMKTS
· Delayed Price · Currency is USD
0.0608
+0.0056 (10.14%)
At close: Dec 5, 2025
Windtree Therapeutics Employees
Windtree Therapeutics had 14 employees as of December 31, 2024. The number of employees decreased by 6 or -30.00% compared to the previous year.
Employees
14
Change
-6
Growth
-30.00%
Revenue / Employee
n/a
Profits / Employee
-$3,487,929
Market Cap
1.86M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Elite Pharmaceuticals | 68 |
| Glass House Brands | 374 |
| CytoDyn | 13 |
| American Oncology Network | 1,914 |
| Northwest Biotherapeutics | 25 |
| Silence Therapeutics | 116 |
Windtree Therapeutics News
- 2 days ago - Windtree Therapeutics (WINT) to Acquire CommLoan: A Strategic Move - GuruFocus
- 18 days ago - Windtree Therapeutics (WINT) Eyes Potential Milestone Payments from License Agreement - GuruFocus
- 22 days ago - Windtree Therapeutics (WINT) Secures $7.5 Million in Strategic Agreement - GuruFocus
- 3 months ago - Windtree Therapeutics Stockholders Approve Key Proposals for Revenue and Profit Generation at ... - GuruFocus
- 3 months ago - BNB treasury firm plunges 77% after Nasdaq delisting notice - Cointelegraph
- 4 months ago - Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025 - GlobeNewsWire
- 4 months ago - Windtree Therapeutics Announces Large Reduction of Preferred Series C and D Shares Outstanding by Conversion and Redemption - GlobeNewsWire
- 4 months ago - BNB Rebounds to $780 After $520M Windtree Buy Commitment, Shows Signs of Stabilizing - CoinDesk